Researcher Spotlight: Carla Casulo, MD Wilmot Cancer Insitute, University of Rochester Dr. Casulo became interested in hematology and lymphoma research as a young child. “My mother worked as a hematology and bone marrow technician at a New York City hospital…
Researcher Spotlight: Danielle Brander, MD Duke University Dr. Brander is a second year faculty member in the Division of Hematologic Malignancies and Cellular Therapy at Duke University. Her interests as a research clinician are improving and developing novel therapies…
Researcher Spotlight: Goldi Kozloski, PhD Sylvester Cancer Center Dr. Kozloski is a Postdoctoral Research Associate at the Sylvester Cancer Center at the University of Miami and a recipient of a 2012 Postdoctoral Fellowship Grant from the Lymphoma Research Foundation…
Researcher Spotlight: Jianguo Tao, MD, PhD H. Lee Moffitt Cancer and Research Institute Though available therapies for lymphoma are becoming increasingly effective at slowing disease progression and prompting remissions, many patients eventually develop drug resistance that allows their disease…
Researcher Spotlight: Andre Goy, MD, MS John Theurer Cancer Center Dr. Goy is the Chairman and Director of the John Theurer Cancer Center in Hackensack, NJ, where he is also Chief of the Division of Lymphoma. At John Theurer,…
Researcher Spotlight: Paul Barr, MD Wilmot Cancer Institute at the University of Rochester Medical Center Dr. Barr is Assistant Professor of Medicine and Director of the Clinical Trials Office for the Wilmot Cancer Institute at the University of Rochester…
Researcher Spotlight: Thomas M. Habermann, MD Mayo Clinic, Rochester Dr. Thomas Habermann is Professor of Medicine at Mayo Clinic in Rochester and current Chair-Elect of the Lymphoma Research Foundation (LRF) Scientific Advisory Board (SAB). His career as a lymphoma researcher…
Researcher Spotlight: Gita Thanarajasingam, MD Mayo Clinic, Rochester Dr. Thanarajasingam’s LCRMP project proposes a new way of looking at side effects (toxicity) of lymphoma therapies. Many standard lymphoma treatment plans now include therapies that are taken continuously over long…
Researcher Spotlight: Alex Herrera, MD Beckman Research Institute at the City of Hope Dr. Herrera’s project for the Lymphoma Clinical Research Mentoring Program (LCRMP) tests a combination of pembrolizumab (Keytruda) and vorinostat (Zolinza), a histone deacetylase inhibitor (HDAC), in…
Researcher Spotlight: Natalie Galanina, MD The University of Chicago Though ibrutinib (Imbruvica) has helped a large number of lymphoma patients, many patients treated with ibrutinib eventually develop a resistance to the therapy and relapse. Dr. Galanina’s Lymphoma Clinical Research Mentoring…